The Access SARS-CoV-2 IgG antibody test features market-leading sensitivity and specificity. Sensitivity and specificity matter because tests without extremely high accuracy could lead to large numbers of incorrect results, potentially resulting in dangerous consequences.

  • The Access SARS-CoV-2 IgG assay is being validated against over 1,000 negative broad population-based samples—significantly more than the number of samples required by the FDA for Emergency Use Authorization 
  • 100% sensitivity and 99.8% specificity—one of the highest dual rates for SARS-CoV-2 antibody tests in the market 
  • Releasing a standalone SARS-CoV-2 IgG test and not a combined IgG-IgM may be more clinically informative

The Access SARS-CoV-2 IgG Antibody Test is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .

Buy the Access SARS-CoV-2 IgG Antibody Test for Detecting SARS-CoV-2 for Your WorkPlace

If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the Access SARS-CoV-2 IgG Antibody Test for Detecting SARS-CoV-2 for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA)

If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the Access SARS-CoV-2 IgG Antibody Test for Detecting SARS-CoV-2 or other rapid tests approved by the TGA.

Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Kindly use the webchat to contact us. This is the most efficient way for us to track and respond to your query. Thank you for your understanding.

Proudly trusted by hundreds of organisations across the Globe

Stay up to date with Rapid Test & Trace Australia

Scroll to Top